2020
DOI: 10.1007/s11356-020-08991-y
|View full text |Cite
|
Sign up to set email alerts
|

Ochratoxin A–induced genotoxic and epigenetic mechanisms lead to Alzheimer disease: its modulation with strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(14 citation statements)
references
References 235 publications
1
13
0
Order By: Relevance
“…The mechanism of action is considered to be the inhibition of hepatic protein synthesis through competitive inhibition of phenylalanyl-t-RNAsynthetase with phenylalanine (Konrad and R€ oschenthaler, 1977;Creppy et al, 1979); however, renal leakage of albumin caused by kidney lesions is thought to be a possible contributor (Huff et al, 1988). The inhibitory effect of OTA on protein synthesis (Niaz et al, 2020) would be the cause of its immunosuppressive effect due to the depression of antibody responses and the impaired replacement of immune cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The mechanism of action is considered to be the inhibition of hepatic protein synthesis through competitive inhibition of phenylalanyl-t-RNAsynthetase with phenylalanine (Konrad and R€ oschenthaler, 1977;Creppy et al, 1979); however, renal leakage of albumin caused by kidney lesions is thought to be a possible contributor (Huff et al, 1988). The inhibitory effect of OTA on protein synthesis (Niaz et al, 2020) would be the cause of its immunosuppressive effect due to the depression of antibody responses and the impaired replacement of immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…Besides its nephrotoxic properties, ochratoxin displays immunotoxicity (Al-Anati and Petzinger, 2006), and it is a potent inhibitor of protein synthesis (Niaz et al, 2020). Due to its long half-life, OTA also can accumulate in the food chain (Gupta, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…In 1993, based on demonstrated carcinogenicity in animal studies, IARC (International Agency for Research on Cancer) identified OTA as a possible human carcinogen and included this mycotoxin in group 2B [ 8 ]. OTA toxicity is presumably due to its direct genotoxic effect through DNA binding and/or epigenetic or non-genotoxic mechanisms [ 1 , 9 ]. Pharmacokinetic characteristics such as long half-life time (35–70 days), high affinity for proteins (particularly serum albumin), and multiple active compounds obtained through OTA metabolism facilitate even more bio-accumulation and detrimental effects on human health [ 1 , 2 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Cell cultures experiments demonstrated that OTA increased apoptosis-related indices, mitochondrial dysfunction, mitochondria-dependent apoptosis activation, and interfered with cytokine pathways [ 9 , 16 ]. In HK-2 cells, OTA induced apoptosis through regulation of the PTEN/AKT signaling pathway via disrupting lipid raft formation [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…The authors suggested that further epidemiological investigations are essential to reduce the progress of neurodegeneration. Niaz et al (2020) highlighted the underlying mechanisms of ochratoxin A regarding genotoxicity and epigenetic modulations that lead to Alzheimer's disease. The authors recommended several phytochemicals, drugs, and trace elements to attenuate ochratoxin A-mediated effects; however, further studies are necessary to understand the exact mechanisms.…”
mentioning
confidence: 99%